The Current State of the Art of Quantitative Phosphoproteomics and Its Applications to Diabetes Research
Overview
Affiliations
Protein phosphorylation is a fundamental regulatory mechanism in many cellular processes and aberrant perturbation of phosphorylation has been implicated in various human diseases. Kinases and their cognate inhibitors have been considered as hotspots for drug development. Therefore, the emerging tools, which enable a system-wide quantitative profiling of phosphoproteome, would offer a powerful impetus in unveiling novel signaling pathways, drug targets and/or biomarkers for diseases of interest. This review highlights recent advances in phosphoproteomics, the current state of the art of the technologies and the challenges and future perspectives of this research area. Finally, some exemplary applications of phosphoproteomics in diabetes research are underscored.
Zhang H, Bensaddek D J Proteome Res. 2025; 24(2):526-536.
PMID: 39842810 PMC: 11811991. DOI: 10.1021/acs.jproteome.4c00690.
Dakup P, Feng S, Shi T, Jacobs J, Wiley H, Qian W Molecules. 2023; 28(3).
PMID: 36770810 PMC: 9919559. DOI: 10.3390/molecules28031143.
Ondrej M, Rehulka P, Rehulkova H, Kupcik R, Tichy A Int J Mol Sci. 2020; 21(11).
PMID: 32492839 PMC: 7312998. DOI: 10.3390/ijms21113971.
Thingholm T, Ronnstrand L, Rosenberg P Cell Mol Life Sci. 2020; 77(16):3085-3102.
PMID: 32076742 PMC: 7391401. DOI: 10.1007/s00018-020-03473-3.
Zhang K, Hu D, Deng S, Han M, Wang X, Liu H Mikrochim Acta. 2019; 186(2):68.
PMID: 30627783 DOI: 10.1007/s00604-018-3177-8.